Pre-exposure and Post-exposure prophylaxis for dog bites
نویسندگان
چکیده
منابع مشابه
Pre-exposure and Post-exposure Prophylaxis for Dog Bites
Sir, The recent report on ‘pre-exposure and post-exposure prophylaxis for dog bites’ is very interesting.[1] Bertozzi et al. suggested that ‘monoclonal antibodies represent a promising alternative to traditionally used polyclonal products, and countries with chronic shortages of human rabies immunoglobulin (HRIG) and equine rabies immunoglobulin (ERIG) would benefit greatly from replacement of ...
متن کاملPattern of Pediatric Animal Bites and Post Exposure Prophylaxis in Isfahan Province-Iran, 2015
Background: The incidence of animal bite is increasing in Iran and there is lack of knowledge about animal bite in children. Hence, the aim of this study was to describe the characteristics of animal bite in children and also evaluate delayed time of post exposure prophylaxis(PEP) in children. Materials and Methods: This cross-sectional study was conducted on 172 children cases of animal bites ...
متن کاملPreparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis.
Although RCTs have not been conducted to establish the effıcacy of non-occupational postexposure prophylaxis (nPEP), studies in nonhuman primates have demonstrated protection with nPEP; observational data support the effıcacy of PEP for occupational exposures; and several studies have esablished the feasibility of nPEP delivery in various setings. Based on these data, the CDC and public health ...
متن کاملpre-exposure and post-exposure prophylaxis of crimean-congo hemorrhagic fever
context crimean-congo hemorrhagic fever (cchf) is a tick-borne viral disease with a mortality rate of 30% to 80% and reported from more than 30 countries in asia, africa, south-eastern europe, and the middle east. it is a zoonotic viral disease and an important health problem. in endemic areas, livestock handlers, livestock market workers, skin processors, veterinary staff, farmers, and healthc...
متن کاملPre-exposure Prophylaxis (PrEP)
In 2012, the US Food and Drug Administration (FDA) approved Truvada to be used as PrEP by HIV negative people who are at high risk of sexually acquired HIV infection. The US Centre for Disease Control has since developed guidelines and recommended PrEP be used by people at high risk of HIV acquisition via sexual transmission or injection drug use (http://www.cdc.gov/hiv/prevention/research/prep/).
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: African Journal of Paediatric Surgery
سال: 2017
ISSN: 0189-6725
DOI: 10.4103/ajps.ajps_66_16